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Nitric Oxide–Mediated Augmentation of Polymorphonuclear Free Radical
Generation After Hypoxia-Reoxygenation
By Sonia Sethi, Mahendra Pratap Singh, and Madhu Dikshit
Polymorphonuclear leukocytes (PMNLs), nitric oxide (NO),
calcium, and free radicals play an important role in hypoxia/
ischemia and reoxygenation injury. In the present study, NO
donors, sodium nitroprusside (SNP), and diethylamine-NO
(DEA-NO) at low concentrations (10 and 100 nmol/L) potenti-
ated, while higher (10 mmol/L to 10 mmol/L) concentrations
inhibited free radical generation response in the rat PMNLs.
Free radical generation response was found to be signifi-
cantly augmented when hypoxic PMNLs were reoxygenated
(hypoxia-reoxygenation [H-R]). This increase in free radical
generation after reoxygenation or SNP (10 nmol/L) was
blocked in the absence of extracellular calcium. SNP (10
nmol/L) or H-R–mediated increases in the free radical genera-
tion were prevented by the pretreatment of PMNLs with NO
scavenger (hemoglobin), the polyadenine diphosphate (ADP)-
ribosylation synthase inhibitor (benzamide) or the calcium
channel antagonist (felodipine). A significant augmentation
in the nitrite and intracellular calcium levels was observed
during hypoxia. Hemoglobin pretreatment also blocked the
increase in intracellular calcium levels due to SNP (10 nmol/L)
or hypoxia. Thus, increased availability of NO during SNP
treatment or H-R, may have led to an ADP-ribosylation–
mediated increase in intracellular calcium, thereby increas-
ing the free radical generation from the rat PMNLs.
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THE ROLE OF polymorphonuclear leukocytes (PMNLs) inischemia/hypoxia-reperfusion damage has been demon-
strated in a variety of organs such as the heart, lungs, kidneys,
brain, liver, and in striated muscles and the gastrointestinal
tract.1-3 Migration of PMNLs into the ischemic tissue as early as
10 minutes after ischemia and increases with time and reperfu-
sion have been reported.4,5 Augmentation of reactive oxygen
species (ROS) generation, chemotaxis, adherence, release of
other cytotoxic substances, and upregulation of opsonic recep-
tors in the activated PMNLs after reoxygenation has also been
demonstrated.3,6
PMNLs, which play an important role in ischemic reoxygen-
ation injury, synthesize nitric oxide (NO) in addition to ROS
from L-arginine by the enzyme nitric oxide synthase (NOS).7
Peroxynitrite production in PMNLs has also been found to
mediate cytotoxicity.7 By contrast, the involvement of NO in the
inhibition and scavenging of free radicals has also been
demonstrated.8 Recently, it has been shown that the low
concentrations (nmol/L) of NO enhanced the free radical
generation in PMNLs, while higher concentrations (µmol/L)
inhibited it.9-11 NO in higher concentrations inhibits the nicotin-
amide adenine dinucleotide phosphate (NADPH) oxidase activ-
ity and scavenges free radicals.8-11 However, the mechanisms of
the increase in ROS generation induced by NO are not clearly
understood. Most of the biologic functions of NO are mediated
by modification of the heme group, thiol groups, or by poly-
adenine diphosphate (ADP)-ribosylation.12,13 NO in PMNLs
has also been shown to cause poly ADP-ribosylation of various
proteins and thus modulate enzyme activities.9
Protection against ischemia and reperfusion injury has been
reported after pretreatment with NOS inhibitors, blockade of
neutrophil adherence, or inhibition of free radicals.3,14,15 Re-
cently Hewett et al16 have shown that the inducible NOS-
mediated NO production in astrocytes potentiates N-methyl-D-
aspartate (NMDA) receptor-dependent neuronal death after a
hypoxic/ischemic insult. However, some reports also indicate a
deleterious or negligible effect of NOS inhibitors.17 It is likely
that the increased concentration of NO in ischemia/hypoxia due
to decreased degradation18 or increased synthesis16 might
modulate ROS generation from PMNLs during ischemia and
reperfusion injury. Therefore, we investigated the involvement
of NO in ROS generation from the normal and reoxygenated
PMNLs after hypoxia.
MATERIALS AND METHODS
Materials. Aminoguanidine, arachidonic acid (AA), catalase, dex-
tran T-500, flavin adenine dinucleotide (FAD), hemoglobin (Hb), lactate
dehydrogenase (LDH), luminol, lucigenin, Fura-2 AM, formyl-
methionyl-leucyl-phenylalanine (FMLP), bNADPH-reduced form, N-(1
naphthyl) ethylene diamine, nitrate reductase, o-dianisidine, phorbol
esters (phorbol myristate acetate [PMA]), phosphoric acid, sodium
nitroprusside (SNP), sodium pyruvate, sulfanilamide, superoxide dismu-
tase (SOD), zymosan particles, and Histopaque (1077 and 1119) were
purchased from Sigma Chemical Co (St Louis, MO). Diethylamine
nitric oxide complex sodium salt (DEA-NO), 7-nitroindazole, and
benzamide were procured from Research Biochemicals International
(Natick, MA). Felodipine was a gift from Astra IDL (Banglore, India).
Sodium nitrite was obtained from Glaxo India (Bombay, India). All
other chemicals used in the present study were of analytical grade (SRL,
Bombay, India).
Preparation of the reagents. Stock solutions of FMLP (100 µmol/
L), PMA (1.625 mmol/L), felodipine (0.5 mmol/L), Fura-2 AM (5
mol/L) and luminol (100 mmol/L) were made in dimethyl sulfoxide
(DMSO), while a stock solution of AA (5 3 1022 mol/L) was prepared
in alcohol and sodium carbonate; further dilutions were made in normal
saline. Solutions of lucigenin (50 mmol/L) and aminoguanidine (0.5
mol/L) were prepared in water. Benzamide (0.2 mol/L) was dissolved in
methanol. Opsonized zymosan (OZ) was made by treating washed
zymosan particles with fresh autologous serum for 30 minutes at 37°C,
then removing the serum by centrifugation. The particles were resus-
pended in Hanks’ Balanced Salt Solution (HBSS) and a stock solution
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of 12.5 mg/mL was stored in 100-µL aliquots at 270°C. Hemoglobin
(0.5 mmol/L) solution was prepared in normal saline.
PMNLs isolation. Rat blood PMNLs were obtained from male
Sprague Dawley rats (130 to 150 g) by the Boyum method.19 Blood was
collected by cardiac puncture in sodium citrate (0.129 mol/L, pH 6.5,
9:1, vol/vol) under ether anesthesia from normal animals. Platelet-rich
plasma was removed by centrifugation at 250g for 20 minutes at 20°C
(Sigma centrifuge, Osterode, Germany) and the buffy coat was sub-
jected to dextran sedimentation as described previously.20 PMNLs were
further purified on Histopaque-density gradient at 700g for 30 minutes
at 25°C. The PMNL-rich layer was recovered at the interface of
Histopaque 1119/1077 and was washed three times with HBSS (sodium
chloride 138 mmol/L, potassium chloride 2.7 mmol/L, disodium
hydrogen phosphate 8.1 mmol/L, potassium dihydrogen phosphate 1.5
mmol/L, magnesium chloride 0.6 mmol/L, calcium chloride 1.0 mmol/L,
glucose 10 mmol/L, pH 7.4). The viability of the cells, tested by trypan
blue exclusion, was never less than 95%. Before experiments, PMNLs
were kept at 4°C for no more than 2 to 3 hours.
Estimation of LDH activity. LDH activity was measured8 in the
supernatant and in the PMNLs lysate after the disruption of PMNLs by
sonication. The amount (%) of the enzyme released in each set was
calculated relative to the total activity present in the supernatant and in
the lysate.
Measurement of chemiluminescence response. Free radical genera-
tion from PMNLs stimulated with various inducers such as AA (1 to 5 3
1025 mol/L), FMLP (1 µmol/L), OZ (1.25 µg) or PMA (3 3 1028
mol/L) was measured at 37°C using a dual channel lumiaggregometer
(Model 560; Chronolog Corp, Havertown, PA) with constant stirring at
900 rpm. Chemiluminescence is reported as units calculated from the
maximum output (obtained from stimulated PMNLs) divided by the
‘‘gain setting’’ of the instrument.8 An assay mixture (1,000 µL)
contained 1 to 5 3 106 PMNLs, 10 µmol/L luminol (LCL), or 50 µmol/L
of lucigenin (LUCDCL), the test substance and FMLP (1 3 1026
mol/L), AA (1 3 1025 mol/L), OZ (1.25 µg) or PMA (3 3 1028 mol/L).
The effect on the AA (1 3 1025 mol/L)-induced chemiluminescence
response of pretreatment with different concentrations of sodium
nitroprusside (SNP, 10 nmol/L to 10 mmol/L), DEA-NO (10 nmol/L to
1 mmol/L), poly-ADP-ribosylation inhibitor (benzamide, 2 3 1023
mol/L), hemoglobin (Hb, 5 or 10 µmol/L), calcium channel antagonist
(felodipine, 5 3 1026 mol/L), and NOS inhibitor (aminoguanidine, 5 3
1023 mol/L) was studied. Chemiluminescence responses were also
studied in the absence of extracellular calcium (a calcium-free me-
dium).
Preparation of hypoxic and hypoxic-reoxygenated cells. Rat PMNLs
were subjected to hypoxic conditions by suspending the cells in HBSS,
which was sponged with nitrogen gas for 30 minutes, and the partial
pressure of oxygen was then measured to assess the oxygen depletion.
Partial pressures of oxygen (pO2) and pH (7.3 6 0.007) were measured
in the cells suspended in HBSS before and after hypoxia (H) and
reoxygenation (H-R) using a blood gas analyzer (Eschweiler System C
2000; Keil, Germany). PMNLs were incubated in the oxygen-depleted
HBSS for 30 minutes at 37°C and pO2 was measured at the end of the
incubation time (pO2 68.05 6 3 mm Hg, n 5 90). PMNLs were
reoxygenated by suspending the cells in normoxic HBSS (pO2 120.9 6
2.6 mm Hg, n 5 90) after centrifugation, and pO2 was again measured
(117.2 6 4.2 mm Hg, n 5 50). Viability of the cells was measured at the
end of the experiment by a trypan blue exclusion test (96% 6 1.3%) and
LDH release, which was 7.29% for normoxic cells, and was unchanged
after hypoxia and hypoxia-reoxygenation.
Measurement of the myeloperoxidase (MPO) activity. Experiments
were performed to determine the AA (1 3 1025 mol/L)-induced MPO
release from PMNLs granules during H and H-R. Enzyme activity was
estimated in the supernatant, and the remaining activity was estimated
in the lysed PMNLs preparations by the methods described earlier.12
Briefly, 0.1 mL lysate or supernatant was incubated in a 2.5-mL
phosphate buffer (pH 6.2) with 0.05% hydrogen peroxide and O-
dianisidine (250 µg) at 37°C for 30 minutes. Reaction was stopped by
adding sodium azide, and the absorbance of the solutions was read at
460 nm. The percentage of the enzyme released was calculated relative
Fig 1. (Top) Effect of hypoxia for different time intervals (10, 20,
and 30 minutes) and reoxygenation (30 minutes) on free radical
generation. (Bottom) Effect of variable time of reoxygenation (10, 20,
and 30 minutes) on hypoxic cells. Cells were subjected to hypoxia for
15 (solid bars) or 30 (empty bars) minutes. Free radical generation
response was induced by AA (1 to 5 3 1025 mol/L) after H-R. *P F .01
in comparison with the control.
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to the total activity (obtained in each set by adding the activities
estimated in supernatant and in the lysate).
Nitrite measurement. Nitrite contents in the normal control, H, and
H-R PMNLs were measured by diazo formation.21 The cell suspensions
(5 3 107 cells/mL) were incubated in normoxic, hypoxic, and reoxygen-
ated conditions in the presence of superoxide dismutase and catalase (50
U/mL); the cells were then sonicated and supernatants were used for
nitrite estimations. The supernatants were incubated with NADPH (40
µmol/L), FAD (4 µmol/L), and nitrate reductase (0.1 U) for 30 minutes
at 37°C. The reaction mixture was then treated with lactate dehydroge-
nase (2 U/mL) and sodium pyruvate (5 µmol/L) and incubated for a
further 20 minutes at 37°C. The color was developed by using Griess
reagent, and absorbance was recorded at 548 nm after a 30-minute
incubation at 37°C. The amount of nitrite was calculated from a
standard curve of sodium nitrite.
Measurement of intracellular calcium levels. The PMNLs sus-
pended in calcium-free HBSS were loaded with Fura 2-AM (3 µmol/L)
for 60 minutes at 4°C. After 60 minutes, the cells were diluted twofold
with calcium-free HBSS and centrifuged, resuspended in normoxic or
hypoxic HBSS, and incubated at 37°C for 30 minutes. [Ca12]i was
estimated by using the method of Grynkiewiez et al.22
Calculations and statistical analysis. Each experimental group
consisted of at least four or five sets of experiments. Results were
expressed as the mean 6 standard error (SE) for separate experiments,
and comparisons were made by paired Student’s t-test or by one way
analysis of variance for multiple comparisons of three or more groups.
When F was significant, the differences between individual groups were
compared with t-test results. The differences were considered to be
statistically significant when P value was less than .05.
RESULTS
Effect of hypoxia-reoxygenation on the rat PMNLs chemilu-
minescence response induced by various agents. PMNLs
were subjected to hypoxia for variable time intervals (10, 20,
and 30 minutes) and then reoxygenated for 30 minutes. There
was an increase in the AA-induced free radical generation after
reoxygenation and no significant difference between hypoxia
for 20 and 30 minutes was observed (Fig 1). In another set of
experiments, cells were subjected to 10-, 20-, and 30-minute
periods of reoxygenation after 15 and 30 minutes of hypoxia
(Fig 1). Although 10 minutes of hypoxia followed by 30
minutes of reoxygenation was sufficient to induce an increase in
free radical generation, we observed a significant and consistent
increase at 30 minutes of hypoxia and 30 minutes of reoxygen-
ation. Therefore, in all of the subsequent studies, 30 minutes of
hypoxia followed by 30 minutes of reoxygenation was used
(Fig 2A). A significant increase in the luminol, as well as the
lucigenin-dependent chemiluminescence response induced by
FMLP, OZ, or PMA, was also observed after reoxygenation (30
minutes) of the hypoxic (30 minutes) rat PMNLs (Table 1).
AA-induced MPO release from the normoxic cells was 24% 6
6%, which was not altered after hypoxia (30% 6 5%) or H-R
(31% 6 6%).
Effect of NO donors on AA induced chemiluminescence
response of rat PMNLs. Pretreatment of rat peripheral PMNLs
with SNP or DEA-NO for 10 to 20 minutes increased the
AA-induced chemiluminescence response at 10 and 100 nmol/L
concentrations (Figs 2B and 3). However, higher concentrations
(10 µmol/L to 10 mmol/L) reduced the LCL response signifi-
cantly (Figs 2B and 3).
Modulation of chemiluminescence response in the SNP
pretreated cells by intracellular and extracellular calcium.
While AA-induced LCL response in the normoxic cells was not
altered in the absence of extracellular calcium, potentiation in
the AA-induced LCL response after H-R was not observed in
the absence of extracellular calcium (Fig 4). Interestingly,
augmentation in the AA-induced LCL response in the presence
of the NO donor SNP (10 nmol/L) was also blocked when
extracellular calcium was absent (Fig 4).
Effect of SNP pretreatment, hypoxia, or H-R on the intracel-
lular calcium levels. Intracellular calcium levels were found
to be augmented after the addition of 10 nmol/L SNP to the rat
PMNLs (Fig 4). A significant increase in intracellular calcium
levels was also observed after hypoxia, and this increase did not
revert back to the normal control level after reoxygenation (Fig
Fig 2. (A) AA-induced chemilumi-
nescence response in normoxic (C),
hypoxic (H), and reoxygenated (H-R)
PMNLs (5 3 106 cells). (B) AA-in-
duced chemiluminescence response
in SNP pretreated cells. SNP was
used at 10 nmol/L and 100 mmol/L
concentrations.
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4). In the presence of hemoglobin (5 µmol/L) an increase in the
intracellular calcium levels after SNP pretreatment or hypoxia
was blocked (Fig 4). However, Hb had no significant effect on
the basal calcium levels in the normoxic cells (Fig 4).
Effect of hypoxia and H-R on the PMNLs nitrite content.
Nitrite content was measured in the normoxic, H, and H-R
PMNLs cell suspensions. PMNLs nitrite concentrations (1.15 6
0.07 µmol/L/5 3 107 cells) after hypoxia were found to be
significantly augmented (42% 6 5%, P , .01) in comparison to
the control (Fig 5). While AA stimulation also increased the
nitrite content in the PMNLs, there was no significant difference
in normoxic versus hypoxic or H-R cells (data not shown).
Effect of hemoglobin, benzamide, and felodipine pretreat-
ment on SNP or H-R induced increases in the chemilumines-
cence response. The H-R or SNP-induced potentiation of the
AA-induced PMNLs free radical generation response was prevented
by the addition of Hb to the hypoxic cells or by the pretreatment of
cells with benzamide or felodipine (Figs 6 and 7).
Effect of NOS inhibitors on the chemiluminescence response
after H-R. Aminoguanidine pretreatment prevented the enhanc-
ing effect of H-R on the AA-induced chemiluminescence
response (Fig 7). Another NOS inhibitor, 7-nitroindazole (1 3
1023 mol/L), was also used to assess the effect of NOS
inhibition on H-R–mediated augmentation of OZ-induced che-
miluminescence response (Table 1). OZ-induced LCL re-
sponses in normoxic and H-R PMNLs in the presence of
7-nitroindazole were 639.36 6 93.47 and 671.56 6 70.03 (n 5
20) chemiluminescence units, respectively.
DISCUSSION
The results obtained in the present investigation suggest that
NO donors had a biphasic effect on the rat PMNLs free radical
generation response. Low concentrations (10 and 100 nmol/L)
potentiated, but higher concentrations (10 µmol/L to 10 mmol/L)
attenuated ROS generation from the rat PMNLs. We postulate
that H-R increases the NO level causing ADP-ribosylation and
increases the intracellular calcium level, which potentiates
PMNLs free radical generation.
Rubanyi et al23 have demonstrated the scavenging role of NO
on the PMNLs superoxide radicals. Other investigators have
shown that augmentation in the exogenous or endogenous NO
inhibits NADPH-oxidase activity and scavenges free radi-
cals.8,24,25 An increase in the intracellular calcium levels in a
guanosine 38-58 cyclic monophosphate (cGMP) independent
manner by SNP in platelets, endothelial cells, and PMNLs has
been observed.11,26,27 Consistent with these results, we also
observed an increase in the intracellular calcium levels along
with augmented chemiluminescence response in the presence of
SNP at 10 nmol/L concentration. In contrast, higher concentra-
tions (10 µmol/L to 10 mmol/L) inhibited free radical genera-
tion8 (Figs 2 and 3). We also observed that benzamide, an ADP
ribosylation inhibitor,12,28 and felodipine, an inhibitor of cal-
cium channels on the PMNLs,29 inhibited SNP-mediated aug-
mentation in the chemiluminescence response. SNP did not
augment ROS generation in the calcium-deficient medium.
Bromo cGMP (a cell permeable analogue of cGMP) did not
modify the free radical generation response (data not shown).
Thus, it appears that NO donors (SNP and DEA-NO), possibly
by ADP-ribosylation–mediated mechanisms, raised the intracel-
lular calcium, which augments ROS generation in the rat
PMNLs.
Studies on inflammation, ischemia, and reperfusion have
recognized PMNLs as the principal participant and effector
cells in acute inflammatory conditions.1,2 The availability of NO
during hypoxia/ischemia has been found to be augmented.16,18
Fig 3. Histogram showing ef-
fect of SNP (open bars) and
DEA-NO (hatched bars) at differ-
ent concentrations (10 nmol/L to
10 mmol/L) on the AA-induced
PMNLs chemiluminescence re-
sponse. *P F .05, **P F .01, and
***P F .001 in comparison with
the control.
Table 1. Effect of H-R on PMNLs Chemiluminescence Response
by Various Inducers
Inducer (type of
response)
No. of
Experiments Control H-R
AA (LCL) 50 586.45 6 36.5 1,202.65 6 51.2*
AA (LUCDCL) 30 999.73 6 71.65 1,861.33 6 112.39*
FMLP (LCL) 5 319.90 6 19.3 745.48 6 96.9*
PMA (LCL) 15 379.00 6 33.4 862.6 6 71.6*
OZ (LCL) 15 880.45 6 70.86 1,496.94 6 138.36*
Values are mean 6 SE.
*P , .01 in comparison to the respective controls.
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To delineate the biological importance and relevance of NO-
mediated increases in free radical generation, we investigated
the role of NO in H-R–mediated increases in free radical
generation response. Reoxygenation of PMNLs and endothelial
cells in vitro after brief periods of hypoxia has been shown to
augment free radical generation,6,8 a result replicated in the
present study. We have found that nitrite contents in the hypoxic
cell suspensions paralleled the concentrations of NO donors
used, which also potentiated free radical generation response in
the normal PMNLs. When the cells were incubated in the
presence of Hb, a NO scavenger,30 during hypoxia and reoxygen-
ation, there was no increase in the free radical generation,
suggesting involvement of NO. During hypoxia there was a
significant increase in the intracellular calcium levels, which did
not revert back to the control levels after reoxygenation. In the
cerebellar granule cells, it was reported that hypoxia-induced
elevation of the intracellular calcium was greatly attenuated by
NOS inhibition.31 Interestingly, in the presence of the NO
scavenger, Hb, we observed no increase in the intracellular
calcium in the PMNLs subjected to H-R. Hb did not affect the
basal calcium levels in the control cells (Fig 4). H-R–mediated
augmentation in ROS generation was also totally prevented by
pretreatment of the cells with a calcium antagonist, felodipine.
Furthermore, the basal free radical generation response was
found to be independent of the presence of extracellular calcium
in the normal PMNLs. However, H-R–mediated potentiation in
free radical generation response was totally dependent on the
presence of extracellular calcium (Fig 4), thereby suggesting
that NO mediates an increase in the intracellular calcium during
H-R, which augments the ROS generation.
A significant reduction in the cerebral infarct size in nNOS
(neuronal NOS) knock-out mice32 and augmentation in NO
synthesis due to the induction of NOS after hypoxia/ischemia
has been shown.18,33 It is interesting to observe that NOS
inhibition in the nNOS containing cells protects against ischemia/
hypoxia and reoxygenation injury.28,32 NOS in the PMNLs
resembles nNOS, as shown by specific antibodies and DNA
probes.34,35 However, it has not yet been demonstrated that there
is any interrelationship between NO and calcium in the
augmentation of free radical generation response after H-R in
Fig 4. (Top) AA (1 3 1025 mol/L) stimulated chemiluminescence
response in normoxic, H-R, or SNP (10 nmol/L) pretreated cells in the
presence and absence of calcium. (Bottom) Intracellular calcium
concentration in the normoxic (C), SNP (S, 10 nmol/L) pretreated,
hypoxic (H), and reoxygenated (H-R) PMNLs. Alteration in the cell
calcium levels was estimated in absence of Hb (left set) and in the
presence of Hb (10 mmol/L, right set). *P F .05 and **P F .01 in
comparison with the control.
Fig 5. Nitrite content in normoxic (C), hypoxic (H), and reoxygen-
ated (H-R) cell suspensions. Nitrite was estimated in 5 3 107 cells after
a 30-minute incubation at 37°C. *P F .01 in comparison with the
control.
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the PMNLs. Recently Volk et al36 have shown in human
endothelial cells that the blockade of the receptor-mediated
calcium entry or prevention of intracellular calcium release
inhibits NO-induced interleukin-8 secretion, suggesting an
interrelationship between NO and calcium. Our work shows for
the first time that the NO-mediated increase in the intracellular
calcium in the hypoxic cells is responsible for the increase in
free radical generation after reoxygenation.
Previous research in our laboratory demonstrated the nonspe-
cific interference of L-nitro arginine analogues with the chemi-
luminescence response.37 Chen and Mehta34 have also shown
that L-arginine analogues do not inhibit PMNLs NOS activity.
Therefore, we used 7-nitroindazole (an inhibitor of nNOS28)
and aminoguanidine (a NOS inhibitor38), which inhibited
PMNLs NOS (data not shown) and prevented H-R–mediated
increases in the PMNLs free radical generation. Thus, inhibition
of NO synthesis in PMNLs was protective against H-R–
mediated increases in the free radical generation, indicating the
involvement of NO in this response.
In addition, the role of granular MPO18 release in the
augmentation of chemiluminescence response was also as-
sessed. However, no significant change in MPO release after
AA stimulation from normoxic versus H-R cells was observed.
This indicates that the increase in ROS generation after H-R is
not mediated by MPO. Furthermore, H-R–mediated augmenta-
tion in ROS generation was also prevented by the pretreatment
of the cells with an ADP ribosylation inhibitor, benzamide.
Recently Thiemermann et al28 reported that ADP-ribosylation
inhibitors reduced the infarct size caused by ischemia and
reperfusion of rabbit myocardium and skeletal muscles. In the
Fig 6. (Top) Effect of Hb (10 mmol/L) pretreatment on the chemilu-
minescence response after H-R and SNP (10 nmol/L) pretreatment.
(Bottom) Histogram representing effect of benzamide (2 3 1023
mol/L) on the AA-induced chemiluminescence response of H-R and
SNP pretreated PMNLs. *P F .01 in comparison with the control.
Fig 7. Effect of felodipine (5 3 1026 mol/L; top) or aminoguanidine
(5 3 1023 mol/L; bottom) on the H-R– or SNP-mediated increases in
the free radical generation. *P F .01 in comparison with the control.
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skeletal muscles, inhibition of nNOS by 7-nitroindazole also
decreased the infarct size. However, they did not investigate the
involvement of calcium in the ADP-ribosylation–mediated
injury.28 NO-mediated ADP ribosylation of G protein has been
demonstrated to regulate the intracellular second messenger
level in the bovine ciliary body.39 Regulation of the mitochon-
drial calcium homeostasis in the isolated hepatocyte has also
been shown to be controlled by the protein ADP-ribosyla-
tion.40,41 In the present study, we have achieved the blockade of
H-R–mediated increase in the ROS generation by the calcium
antagonist, NOS, and ADP-ribosylation inhibitors. It, therefore,
appears that during H-R, NO induces ADP-ribosylation, which
increased the intracellular calcium, which in turn, increases the
ROS generation. The role of these mechanisms in hypoxia/
ischemic injury to various organs needs further examination.
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